@entity170 in XXXX : is there any?

@entity1 @entity2249 @entity627 @entity170 @entity5144 @entity4932 @entity1555 @entity572 @entity2693
AIMS: Although considered as a feature of inflammatory @entity627 , there is a lot of controversy around low bone mass in @entity1 with @entity5144 . The aim of this cross-sectional study was to analyze bone mineral density in @entity1 with @entity5144 , as well as to investigate its possible association with some measures of disease activity and functional capacity. SUBJECTS AND METHODS: Sixty-nine @entity1 with established @entity5144 (mean age 56.20    12.23 years) and who have not been treated with specific antiosteoporotic drugs were recruited from the out- @entity1 clinic database. Bone mineral density was measured by dual-energy X-ray absorptiometry at the lumbar spine and at the left hip. Disease activity measures included: duration of morning @entity2693 , tender and swollen joint count, @entity1 's and physician's global assessment, presence of dactylitis and @entity4932 , ESR, CRP and Disease Activity Score 28. Health Assessment Questionnaire was used to assess functional status. RESULTS: According to WHO definition, spinal @entity170 was found in 7.2% of @entity1 , @entity572 in 1.4% of @entity1 and @entity2249 in 2.9% of @entity1 . There was no significant association of any of the measures of disease activity with @entity1555 at any site. Higher HAQ scores were associated with lower total hip @entity1555 . CONCLUSIONS: In our sample of @entity1 with @entity5144 we did not find increased prevalence of @entity170 . There was no association of @entity1555 with indices of disease activity, while negative correlation was found between HAQ and total hip @entity1555 .
